Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Eri Sugiyama

2PUBLICATIONS
26CO-AUTHORS
AutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 04, 2026
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Tomoko Kobayashi, Shintaro Iwama, Eri Sugiyama

|Feb 02, 2020
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i>-mutated non-small cell lung cancer.

Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi

Pageof 1

Frequent Collaborators

2 joint publications

Hiroyoshi Nishikawa

1 joint publications

Yosuke Togashi

1 joint publications

Sayoko Shinya

1 joint publications

Yasuko Tada

1 joint publications

Genichiro Ishii

1 joint publications

Yasushi Shintani

1 joint publications

Tomoko Kobayashi

1 joint publications

Shintaro Iwama

1 joint publications

Shohei Koyama

1 joint publications

Tetsushi Izuchi

Frequent Collaborators

2 joint publications

Hiroyoshi Nishikawa

1 joint publications

Yosuke Togashi

1 joint publications

Sayoko Shinya

1 joint publications

Yasuko Tada

Top Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on : Feb 03, 2023

2.3K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.1K
See more related videos

Top Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on : Feb 03, 2023

2.3K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.1K
See more related videos